Epigenomics AG (FRA:ECX)

Germany flag Germany · Delayed Price · Currency is EUR
0.8900
+0.0100 (1.14%)
At close: Aug 12, 2025, 10:00 PM CET
58.93%
Market Cap 780.49K
Revenue (ttm) 4.00K
Net Income (ttm) -2.76M
Shares Out 876.95K
EPS (ttm) -3.15
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 30
Average Volume 95
Open 0.8800
Previous Close 0.8800
Day's Range 0.8800 - 0.8900
52-Week Range 0.5000 - 2.3000
Beta 0.86
RSI 53.01
Earnings Date Jul 30, 2025

About Epigenomics AG

Epigenomics AG does not have significant operations. Previously, it was involved in liquid biopsy for the early detection of cancer. The company was founded in 1998 and is based in Heidelberg, Germany. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 1998
Employees 2
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol ECX
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.